Antibodies to Human C1 Esterase Inhibitor

<strong>Antibodies to Human C1 Esterase Inhibitor</strong>_x000D_ <strong>Catalog number:</strong> B2013239_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> C1 Esterase Inhibitor antibodies_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Patel G, Pongracic JA. Hereditary and acquired angioedema Allergy Asthma Proc. 2019 Nov 1;40(6):441-445._x000D_ 2: Busse PJ, Christiansen SC. Hereditary Angioedema N Engl J Med. 2020 Mar 19;382(12):1136-1148._x000D_ 3: Melamed IR, Miranda H, Heffron M, Harper JR. Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study Front Immunol. 2021 Mar 2;12:632744._x000D_ 4: Craig T, Magerl M, Levy DS, Reshef A, Lumry WR, Martinez-Saguer I, Jacobs JS, Yang WH, Ritchie B, Aygören-Pürsün E, Keith PK, Busse P, Feuersenger H, Pawaskar D, Jacobs I, Pragst I, Doyle MK. Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial Lancet. 2022 Mar 5;399(10328):945-955._x000D_ 5: Justiz Vaillant AA, Qurie A. Immunodeficiency 2022 Jul 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–._x000D_ 6: Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1091-1097._x000D_ 7: Riedl M. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema Clin Drug Investig. 2015 Jul;35(7):407-17._x000D_ 8: Berger M, Lefaucheur C, Jordan SC. Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation Transplantation. 2019 Sep;103(9):1763-1775._x000D_ 9: van den Elzen M, Go MFCL, Knulst AC, Blankestijn MA, van Os-Medendorp H, Otten HG. Efficacy of Treatment of Non-hereditary Angioedema Clin Rev Allergy Immunol. 2018 Jun;54(3):412-431._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30243377">10: Wong C, Muguiro DH, Lavergne S, Behling-Kelly E, Goggs R. Pharmacokinetics of human recombinant C1-esterase inhibitor and development of anti-drug antibodies in healthy dogs Vet Immunol Immunopathol. 2018 Sep;203:66-72. </a>_x000D_ _x000D_ <strong>Products Related to Antibodies to Human C1 Esterase Inhibitor can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>